Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FRSH | NIC |
|---|---|---|
| Price | $13.22 | $164.62 |
| Change today | ▲ 3.44% | ▼ 1.11% |
| Market cap | $3.45B | $3.45B |
| Return, 3 months | +27.4% | -0.1% |
| Return, year to date | +7.9% | +36.6% |
| Return, 1 year | +16.9% | +22.8% |
| P/E (TTM) | 21.0 | 18.5 |
| P/B | 3.8 | 1.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 0.80% |
| Revenue growth (YoY, latest qtr) | – | +85.7% |
| Net profit growth (YoY) | – | +57.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 29.7% |
| Return on equity | – | 8.9% |
| Analyst target vs. price | +21.0% | +17.2% |
| Analyst buy share | 75% | 100% |
| RSI (14) | 59 | 42 |
| 30-day volatility | 43.3% | 16.2% |
| Max drawdown, 1 year | -48.8% | -17.9% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
